Article - Echosens

Choose your language

CAP VS Abdominal Ultrasound

How can liver fibrosis be assessed without a biopsy? The role of noninvasive tests and controlled-vibration pulse elastography

MASLD vs MASH: what are the differences?

Fierce Healthcare: Not All Noninvasive Imaging Technologies Are Evaluated the Same by Payers

Appropriate Coding and Billing for FibroScan®

Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)

A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH

A call for doubling the diagnostic rate of at-risk MASH

New publication on our new technology Guided VCTE™

Echosens Named a Top Place to Work in 2024 by The Boston Globe

1
2
3
4
5
6
7
8
9
Suivant

"*" indicates required fields

Email

This field is for validation purposes and should be left unchanged.

Country**

Email**